Preparation and Characterization of Simvastatin Nanocapsules: Encapsulation of Hydrophobic Drugs in Calcium Alginate
- 114 Downloads
During past few years, development of methods for physical encapsulation of drugs in biocompatible materials in mild conditions for poorly water-soluble hydrophobic drugs which are sensitive to hydrolytic conditions is of high interest in biomedical and pharmaceutical industries. The encapsulation can improve the drug solubility while decreases its side effects besides controlling its pharmacokinetic profile which results in the overall improvement of the therapeutic efficacy. In the current paper, we provide a detailed protocol for encapsulation of poorly water-soluble hydrophobic drugs which is a development of the previously developed protocol of nanocapsule formation by complex formation on the interface of emulsion droplets. The newly developed protocol is based on nanocapsule formation by complex formation on the interface of emulsion droplets except using no organic solvent for potential targeted drug delivery to glioblastoma cells. Simvastatin as a model of hydrophobic drugs of high hydrolytic sensitivity was encapsulated in calcium alginate hydrogel as a biocompatible matrix using the developed protocol. Simvastatin belongs to a group of mevalonate cascade inhibitors (statins) which have recently been considered as a possible new approach in cancer treatment especially glioblastoma. As a cholesterol biosynthesis inhibitor, it is very important to deliver statins only to target cells and not intact cells using targeted drug delivery strategies to avoid dysregulation of cholesterol biosynthesis in normal tissue. To prepare the statin drug nanocarrier’s, the drug was first dissolved in polysorbate 20 nonionic surfactant solution, and then peptide modified calcium alginate was deposited on the micelles interface at neutral pH and 30 °C. The prepared nanocapsules were spherical in shape and very small in size (i.e., 17 ± 5 nm). The drug content of the nanocapsules was 117.3 mg g−1 and the drug loading efficiency for a 5-mg initial amount of the drug was 23.5% ± 3.1%.
KeywordsCalcium alginate Encapsulation Hydrophobic drugs Nanocapsules Simvastatin
The project was supported by National Institute for Medical Research Development (NIMAD), operating grant number #943267. SG was also supported by Health Science Foundation general operating grant and Research Manitoba New Investigator Operating grant.
- 4.Messana L (2017) Nanotechnology in drug delivery: fundamentals, design, and applications. Scitus Academics LLCGoogle Scholar
- 10.Leong J-Y, Lam W-H, Ho K-W, Voo W-P, Lee MF-X, Lim H-P, Lim S-L, Tey B-T, Poncelet D, Chan E-S (2016) Advances in fabricating spherical alginate hydrogels with controlled particle designs by ionotropic gelation as encapsulation systems. Particuology 24:44–60. https://doi.org/10.1016/j.partic.2015.09.004CrossRefGoogle Scholar
- 16.Alizadeh J, Zeki AA, Mirzaei N, Tewary S, Rezaei Moghadam A, Glogowska A, Nagakannan P, Eftekharpour E, Wiechec E, Gordon JW, Xu FY, Field JT, Yoneda KY, Kenyon NJ, Hashemi M, Hatch GM, Hombach-Klonisch S, Klonisch T, Ghavami S (2017) Mevalonate cascade inhibition by simvastatin induces the intrinsic apoptosis pathway via depletion of isoprenoids in tumor cells. Sci Rep 7:44841. https://doi.org/10.1038/srep44841CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Likus W, Siemianowicz K, Bienk K, Pakula M, Pathak H, Dutta C, Wang Q, Shojaei S, Assaraf YG, Ghavami S, Cieslar-Pobuda A, Los MJ (2016) Could drugs inhibiting the mevalonate pathway also target cancer stem cells? Drug Resist Updat 25:13–25. https://doi.org/10.1016/j.drup.2016.02.001CrossRefPubMedGoogle Scholar
- 18.Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, Freed DH, Hashemi M, Shojaei S, Zeki AA, Ghavami S (2014) Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease. Pharmacol Ther 143(1):87–110. https://doi.org/10.1016/j.pharmthera.2014.02.007CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Ghavami S, Sharma P, Yeganeh B, Ojo OO, Jha A, Mutawe MM, Kashani HH, Los MJ, Klonisch T, Unruh H, Halayko AJ (2014) Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochim Biophys Acta 1843(7):1259–1271. https://doi.org/10.1016/j.bbamcr.2014.03.006CrossRefPubMedGoogle Scholar
- 27.Santhi K, Dhanraj S, Nagasamyvenkatesh D, Sangeetha S, Suresh B (2005) Preparation and optimization of sodium alginate nanospheres of methotrexate. Indian J Pharm Sci 67(6):691–696Google Scholar